# Novel Form of Acquired Long QT Syndrome

> **NCT04169100** · PHASE4 · UNKNOWN · sponsor: **Narrows Institute for Biomedical Research** · enrollment: 25 (estimated)

## Conditions studied

- Long QT Syndrome
- Connective Tissue Diseases
- Rheumatoid Arthritis

## Interventions

- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT04169100
- **Lead sponsor:** Narrows Institute for Biomedical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09-28
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-09-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2022-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04169100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04169100, "Novel Form of Acquired Long QT Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04169100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*